Skin of Color Seminar Series (SOCSS) is organized by SanovaWorks and will be held during May 05 - 06, 2018 at Crowne Plaza Hotel, Times Square, New York, United States of America.
The target audience for this medical event is dermatologists, dermatology residents/fellows, dermatology nurse practitioners and physician assistants specializing in diagnosis, management and treatment of patient outcomes in medical, surgical and aesthetic dermatology. This CME Conference has been approved for a maximum of 11.5 AMA PRA Category 1 Credits.
This is the largest CE event dedicated to trending evidence-based research and new practical pearls for treating skin types III – VI. Earn CE in New York City with direct access to elite experts and an experience unmatched by any other event in dermatology.
Topics include Hair Loss, Acne, Rosacea, Skin Care with Cosmeceuticals, PRP, Psoriasis, Scalp Psoriasis, Skin Cancer, Atopic Dermatitis, Hidradenitis Suppurativa, Nail and Fungal Disorders. Live Demonstrations with Fillers, Injectables, Peels, Lasers, Light and Energy-based Devices for Acne, Pigmentation, Skin Tightening, and Region-specific Facial Rejuvenation: Perioral, Periorbital, Volume Loss, etc.
Learning Objectives :
Upon completion of the seminar, participants should be able to:
• Differentiate skin color classification systems to categorize common skin disorders and cutaneous diseases in patients with skin of color.
• Cite key differences in the skin structure and how it relates to diagnosing and treating common ethnic skin disorders including acne vulgaris, pigment disorders, psoriasis, systemic lupus erythematosus, sarcoidosis, hidradenitis suppurativa, etc.
• Formulate multiple treatment strategies that may be more effective when treating common skin disorders in patients with skin of color.
• Evaluate data from recent clinical trials of biologic response modifiers as treatment options for collagen vascular diseases and granulomatous acne form disorders.
• Detect and manage common skin conditions in skin of color pediatric patients.
Integrate optimal psoriasis treatment plans utilizing biological agents in patients with skin of color.
• Recognize the unique structural nuances of ethic facial anatomy and impact on the natural aging process.
• Identify the efficacy and safety of laser use in patients with skin types of IV to VI, with fewer risks of epidermal adverse events.
• Assess appropriate laser settings for treatments of skin of color patients.
• Identify strategies for the use of neurotoxins, hyaluronic acid fillers for volumization and rejuvenation of the ethnic face including specific anatomical considerations and approaches for the lips, nasolabial folds and chin.
• Describe strategies and techniques for injection and vector placement of neurotoxins and fillers to obtain optimal results and to preempt complications.
• Cite common aesthetic cultural and ethnic practices that may increase occurrence of common skin problems.
Additional details will be posted as soon as they are available.